ZIM (NYSE) Form 144: Affiliate sale of 700,000 shares valued at $19.68M

Rhea-AI Filing Summary

ZIM submitted a Form 144 reporting a proposed sale of ordinary shares by an affiliate. The notice lists prior option exercises on 01/24/2019 (158,426 shares) and 02/03/2021 (546,822 shares), and discloses a sale on 03/11/2026 of 700,000 ordinary shares with a reported value of $19,680,640.00.

Broker information is shown as Oppenheimer & Co. Inc. at 85 Broad St., New York, NY.

Insights

Securities Compliance Analyst

Form 144 notice of affiliate sale; prior option exercises recorded.

The excerpt lists two option exercises by the issuer on 01/24/2019 and 02/03/2021 for 158,426 and 546,822 shares respectively, and a reported sale of 700,000 shares on 03/11/2026 valued at $19,680,640.00. These items are presented as transaction entries and sale reporting.

Cash‑flow treatment and any proceeds recipient beyond the named broker are not detailed in the excerpt; subsequent filings may disclose settlement details or additional selling‑holder information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	705248	19796311.00	120465908	03/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/24/2019	Options Exercised	Issuer			158426	01/24/2019	N/A
Ordinary	02/03/2021	Options Exercised	Issuer			546822	02/03/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eli Glickman 9 ANDREI SAKHAROV STREET P.O. BOX 15067 HAIFA L3 3190500	Ordinary	03/11/2026	700000	19680640.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ZIM's Form 144 disclose about recent insider sales?

The Form 144 reports a sale of 700,000 ordinary shares on 03/11/2026, with a reported value of $19,680,640.00. It also lists prior option exercises of 158,426 and 546,822 shares on 01/24/2019 and 02/03/2021.

Who is listed as the broker for the reported sale in ZIM's filing?

The filing names Oppenheimer & Co. Inc. at 85 Broad St., New York, NY as the broker. The excerpt provides this broker contact detail alongside the securities information.

Does the Form 144 specify how much cash ZIM received from the sale?

The excerpt provides a reported sale value of $19,680,640.00 for 700,000 shares, but it does not state who received proceeds or how proceeds were treated beyond listing the broker.

Are the option exercises in ZIM's Form 144 described as part of the sale?

The filing lists option exercises on 01/24/2019 (158,426 shares) and 02/03/2021 (546,822 shares) under 'Securities To Be Sold' entries. The excerpt does not state that those exercised shares were included in the March 2026 sale.

Who is the selling individual named in the Form 144 excerpt?

The excerpt identifies Eli Glickman with an address in Haifa as a selling party tied to the reported 700,000-share sale recorded on 03/11/2026.